Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Verastem (VSTM) Invested Capital (2018 - 2025)

Historic Invested Capital for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to -$15.5 million.

  • Verastem's Invested Capital fell 17418.06% to -$15.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.5 million, marking a year-over-year decrease of 17418.06%. This contributed to the annual value of -$28.9 million for FY2024, which is N/A changed from last year.
  • Verastem's Invested Capital amounted to -$15.5 million in Q3 2025, which was down 17418.06% from $36.1 million recorded in Q2 2025.
  • Over the past 5 years, Verastem's Invested Capital peaked at $102.6 million during Q1 2021, and registered a low of -$32.4 million during Q1 2025.
  • Its 5-year average for Invested Capital is $47.7 million, with a median of $50.6 million in 2022.
  • Its Invested Capital has fluctuated over the past 5 years, first soared by 8850.85% in 2023, then plummeted by 22941.11% in 2025.
  • Quarter analysis of 5 years shows Verastem's Invested Capital stood at $87.6 million in 2021, then crashed by 45.88% to $47.4 million in 2022, then soared by 75.52% to $83.2 million in 2023, then crashed by 134.74% to -$28.9 million in 2024, then surged by 46.26% to -$15.5 million in 2025.
  • Its last three reported values are -$15.5 million in Q3 2025, $36.1 million for Q2 2025, and -$32.4 million during Q1 2025.